As siRNA mediated therapy further develops, the need for biocompatible, effective delivery vectors, especially for mucosal delivery, is apparent. We report here a novel nanocarrier for siRNA delivery via targeted chemical modification of the polysaccharide chitosan. Although widely used in mucosal drug delivery applications, chitosan is limited by minimal solubility and buffering capacity at physiological pH as well as poor cell transfection efficacy compared to other polycations. We hypothesized that introduction of secondary and tertiary amines to the polymer backbone would enhance its solubility, endosomal escape capability and cytoplasmic siRNA dissociation, thus resulting in highly efficient gene silencing. Successful introduction of imidazole acetic acid (IAA) to chitosan was achieved using carbodiimide chemistry with up to 90% modification. Enhancement in buffering capacity and solubility were demonstrated even at high pH. As predicted, in vitro gene knockdown was greatly enhanced, nearly doubling in efficacy and matching commercially available transfection agents. Preliminary in vivo studies demonstrated effective gene knockdown in mice following intranasal administration of chitosan-IAA-siRNA nanocomplexes. GAPDH silencing was used as a model system and knockdown of up to 60 percent was achieved in the lung tissues. In summary, we have synthesized a biocompatible, mucoadhesive vector for enhanced in-vivo delivery of siRNA.
Journal: TechConnect Briefs
Volume: 2, Nanotechnology 2008: Life Sciences, Medicine & Bio Materials – Technical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show, Volume 2
Published: June 1, 2008
Pages: 338 - 341
Industry sector: Medical & Biotech
Topicss: Biomaterials, Materials for Drug & Gene Delivery